Danish agency updates guideline on adverse events in clinical trial protocols
This article was originally published in SRA
Executive Summary
The Danish Medicines Agency has amended its guideline on clinical trials for human drugs to clarify the obligations of investigators with regard to adverse reactions registration in trial protocols1,2.